🇺🇸 FDA

Company profile · Sponsor

Geron

Geron Netherlands B.V.

ED08311 · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

Geron (ED08311) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ED08311
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. -, -, IMETELSTAT, -, -, -, -, -, -, -

    Geron

    Myelofibrosis

    phase 3 small molecule active

    1 trial

  2. Placebo to Imetelstat, -, -, IMETELSTAT

    Geron

    Myelodysplastic syndromes (MDS)

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Geron?

Geron (ED08311) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Geron sponsor?

We track 2 ClinicalTrials.gov-linked programs for Geron, including -, -, IMETELSTAT, -, -, -, -, -, -, - and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Geron company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.